Charles Schwab’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Charles Schwab’s Portfolio OCAT Stock Details OCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-69,025	Closed	-$582K	–	3086
2015 Q4	$582K	Buy	69,025 +20,900	+43%	+$140K	﹤0.01%	2585
2015 Q3	$202K	Hold	48,125	–	–	﹤0.01%	2957
2015 Q2	$254K	Buy	+48,125	New	+$308K	﹤0.01%	2934

Charles Schwab's OCAT Position: Q1 2016 in Review

Charles Schwab sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 69,025 shares — an estimated $582K sold.

Charles Schwab first reported a position in OCAT in Q2 2015 and held it in 3 quarters. The position peaked at $582K in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

Charles Schwab reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
Charles Schwab sold 69,025 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $582K.
Charles Schwab first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 3 quarters.
Charles Schwab's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $582K in Q4 2015.
1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Charles Schwab's 13F filing for Q1 2016, filed 5 May 2016.